VolitionRx Limited Derivative, Gain (Loss) on Derivative, Net
VolitionRx Limited (VNRX) reported Derivative, Gain (Loss) on Derivative, Net of -$1.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2026-08-13
- VolitionRx Limited derivative, gain (loss) on derivative, net for the quarter ending 2026-06-30 was -$1.37M, a 428.19% decline year-over-year.
- VolitionRx Limited derivative, gain (loss) on derivative, net for the quarter ending 2026-03-31 was $98.64K.
- VolitionRx Limited derivative, gain (loss) on derivative, net for the quarter ending 2025-12-31 was -$594.39K.
- VolitionRx Limited derivative, gain (loss) on derivative, net for the quarter ending 2025-09-30 was $304.44K.
- VolitionRx Limited derivative, gain (loss) on derivative, net for fiscal 2025 was $128.73K.
- VolitionRx Limited derivative, gain (loss) on derivative, net for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- VolitionRx Limited derivative, gain (loss) on derivative, net for fiscal 2023 was $240.31K.
- VolitionRx Limited derivative, gain (loss) on derivative, net for fiscal 2022 was $0.00.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 3 month as first filed | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 6 month as first filed | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 9 month as first filed | Derivative, Gain (Loss) on Derivative, Net 12 month | Derivative, Gain (Loss) on Derivative, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.37M 10-Q · filed 2026-08-13 | -$1.28M 10-Q · filed 2026-08-13 | -$1.87M derived: sum of 3 quarters · filed 2026-08-13 | -$1.57M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $98.64K 10-Q · filed 2026-05-14 | -$495.75K derived: sum of 2 quarters · filed 2026-05-14 | -$191.31K derived: sum of 3 quarters · filed 2026-05-14 | $227.37K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$594.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$289.95K derived: sum of 2 quarters · filed 2026-03-31 | $128.73K derived: sum of 3 quarters · filed 2026-08-13 | $128.73K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $304.44K 10-Q · filed 2025-11-13 | $723.12K derived: sum of 2 quarters · filed 2026-08-13 | $723.12K 10-Q · filed 2025-11-13 | $723.12K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $418.68K 10-Q · filed 2026-08-13 | $418.68K 10-Q · filed 2026-08-13 | $418.68K derived: sum of 3 quarters · filed 2026-08-13 | $418.68K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | $0.00 derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 | $28.76K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $4.87K 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $30.42K 10-Q · filed 2024-11-14 | -$28.46K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $44.47K 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2025-08-14 | $25.55K 10-Q · filed 2024-08-14 | -$28.46K derived: sum of 3 quarters · filed 2025-08-14 | $192.42K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$18.92K 10-Q · filed 2024-05-13 | -$28.46K derived: sum of 2 quarters · filed 2025-03-31 | $192.42K derived: sum of 3 quarters · filed 2025-03-31 | $221.39K derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-12-31 | -$9.53K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $211.34K derived: sum of 2 quarters · filed 2025-03-31 | $240.31K derived: sum of 3 quarters · filed 2025-03-31 | $240.31K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $220.87K 10-Q · filed 2024-11-14 | $249.84K derived: sum of 2 quarters · filed 2024-11-14 | $249.84K 10-Q · filed 2024-11-14 | $249.84K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $28.97K 10-Q · filed 2024-08-14 | $28.97K 10-Q · filed 2024-08-14 | $28.97K derived: sum of 3 quarters · filed 2024-08-14 | $28.97K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | $0.00 derived: sum of 2 quarters · filed 2024-05-13 | $0.00 derived: sum of 3 quarters · filed 2024-05-13 | $0.00 derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | $0.00 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | ||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $0.00 derived: sum of 2 quarters · filed 2017-03-10 | $0.00 derived: sum of 3 quarters · filed 2017-03-10 | -$339.74K 10-K · filed 2017-03-10 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | -$339.74K 10-Q · filed 2016-11-10 | -$2.28M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$339.74K 10-Q · filed 2016-08-11 | -$2.28M derived: sum of 3 quarters · filed 2016-08-11 | $1.85M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | -$339.74K 10-Q · filed 2016-05-13 | -$2.28M derived: sum of 2 quarters · filed 2016-05-13 | $1.85M derived: sum of 3 quarters · filed 2016-05-13 | -$15.43K derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $2.19M derived: sum of 2 quarters · filed 2016-03-11 | $324.31K derived: sum of 3 quarters · filed 2016-03-11 | $1.42M 10-K · filed 2016-03-11 | ||||
| 2014-09-30 | $4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $2.26M derived: sum of 2 quarters · filed 2015-11-04 | $3.36M 10-Q · filed 2015-11-04 | |||||
| 2014-06-30 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$767.00K 10-Q · filed 2015-08-11 | ||||||
| 2014-03-31 | $1.10M 10-Q · filed 2015-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |